Cartesian Therapeutics, Inc. — Director's Dealing 2017

Jun 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-06-01

Reporting Person: SPRINGER TIMOTHY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-01	Common Stock	P	518	$13.75	Acquired	16622	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1237028	Indirect
Common Stock	445576	Indirect

Footnotes

F1: LKST, Inc. is the general partner of Leukon Investments LP. Timothy Springer is the president of LKST, Inc. and the managing member of TAS Partners, LLC. The Reporting Person disclaims beneficial ownership of the securities held by Leukon Investments LP and TAS Partners, LLC except to the extent of his pecuniary interest therein, if any.

F2: Held by Leukon Investments LP.

F3: Held by TAS Partners, LLC.